Now Live: Cboe Europe real-time data for all major European stocks.
opens in 2d 1h 5m
Market closed

Pre-market opens in 1 day 19 hours 35 minutes
Main market opens in 2 days 1 hour 5 minutes

08:24
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).
19.30000 EUR
1
5.46%
Last update Apr 2, 9:55 PM CEST
Market closed
Day range
18.10000
19.30000
Previous close
18.30000
Open
18.20000
Access this stock data via API
Subscribe
Ultragenyx Pharmaceutical Inc.
19.30
1
5.46%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2025 2024 2023 2022
Total reported revenue 673M 470.8M 434.2M 363.3M
Cost of revenue 109M 64.5M 45.2M 28.3M
Gross profit 564M 406.3M 389.0M 335.0M
Operating expense
Research & development 750M 586.4M 648.4M 705.8M
Selling general and admin 349M 270.3M 309.8M 278.1M
Other operating expenses
Operating income -535M -450.4M -569.2M -648.9M
Non operating interest income
Income 25M 30.7M 26.7M 11.1M
Expense 62M 53.0M 66.0M 43.0M
Other income expense 1M -4.3M 60K -20.9M
Pretax income -571M -477.0M -608.5M -701.7M
Tax provision 4M 1.3M -1.8M 5.7M
Net income -575M -478.3M -606.6M -707.4M
Basic EPS -5.8 -6.3 -8.3 -10.1
Diluted EPS -5.8 -6.3 -8.3 -10.1
Basic average shares 98.6M 76.1M 76.5M 72.8M
Diluted average shares 98.6M 76.1M 76.5M 72.8M
EBITDA -474M -393.2M -516.9M -621.2M
Net income from continuing op. -575M -478.3M -606.6M -707.4M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan (individual) and the Venture plan (business) and above.
Market closed

Exchange is currently closed (non-working day)
Main market opens in 2 days 17 hours 35 minutes

14:24
00:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CEST, UTC+02:00).